Volume 9, Number 1—January 2003
Research
Cost Effectiveness of a Potential Vaccine for Human papillomavirus
Table 1
Health and economic outcomes of HPV vaccinationa
Outcome | No vaccination | HPV vaccination |
---|---|---|
Cost, $ | 39,682 | 39,928 |
Incremental cost, $ | 246 | |
Life expectancy, yrs | 28.785 | 28.793 |
Incremental life expectancy, days | 2.8 | |
Quality-adjusted life expectancy, yrs | 27.720 | 27.731 |
Incremental quality-adjusted life expectancy, days | 4.0 | |
Incremental cost effectiveness | ||
$/life year | 32,066 | |
$/quality-adjusted life year | 22,755 |
aHPV, Human papillomavirus.